Full-Time

Senior Research Associate

Posted on 10/25/2024

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior

Framingham, MA, USA

Onsite presence required.

Category
Biology Lab & Research
Biology & Biotech

You match the following Sanofi's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Master’s degree in biology, molecular biology, chemistry, biochemistry, pharmaceutical science, chemical or protein engineering, or related field -OR- bachelor’s degree with 2 years of relevant experience
  • Experience with analytical and biophysical characterization techniques such as HPLC, HIAC, MFI, CE-SDS, cIEF, and various spectroscopy methods
  • Basic statistical data analysis understanding
  • Previous experience in process or lyophilization development is a plus
  • Ability to learn new skills
  • Team and project oriented with strong motivation and work ethic
  • Good communication skills
  • Flexible mindset to support a fast-paced team environment
Responsibilities
  • Execution of formulation, process development, and stability studies for both liquid and lyophilized products across the development life cycle.
  • Analyze, compile, and present data to drive decision making for programs.
  • Support laboratory management and safety programs, including implementation of new equipment and work processes.
  • Utilize good documentation practices in maintaining electronic lab notebook entries and authoring robust technical reports.
  • Support technological application development and implementation, including iLab and other packages.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi differentiates itself from competitors by its strong commitment to scientific innovation and a diverse product portfolio that includes prescription medicines and vaccines. Its goal is to enhance health outcomes and improve the quality of life for people globally by delivering effective and safe healthcare solutions.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA Breakthrough Therapy designation for tolebrutinib boosts Sanofi's neurology leadership.
  • Sanofi's Muse AI tool accelerates patient recruitment, reducing clinical trial timelines.
  • Investment in Zucara Therapeutics strengthens Sanofi's diabetes portfolio with innovative treatments.

What critics are saying

  • Regulatory delays in Japan and China for Sarclisa could impact revenue projections.
  • Liver enzyme elevations in tolebrutinib trials may lead to regulatory scrutiny.
  • Reliance on strategic partnerships poses risks if expected results are not achieved.

What makes Sanofi unique

  • Sanofi's Sarclisa is the first anti-CD38 therapy combined with VRd in the EU.
  • The Care4Rare program focuses on lysosomal storage diseases, offering unique patient solutions.
  • Sanofi's MyWay app enhances patient engagement and medication adherence through digital health.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Professional Development Budget

Parental Leave

INACTIVE